SCHEMBL5169637

SCHEMBL5169637

Nc1ccc(CC(=O)N2CCCCC2)cc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.56
HPGD P15428 5/20 0.56
NPC1 O15118 2/20 0.56
ECE2 P0DPD6 1/20 0.54
POLB P06746 3/20 0.52
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
GAA P10253 3/20 0.47
MAPT P10636 2/20 0.47
RAB9A P51151 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HRH3 Q9Y5N1 1/20 0.45
ALDH1A1 P00352 4/20 0.43
HTT P42858 3/20 0.43
ALOX12 P18054 1/20 0.43
PPID Q08752 1/20 0.42
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5088782 0.98 ECE2 (0.55) SMN1; SMN2HPGDNPC1ECE2POLB
Phosphoric Acid SCHEMBL5257279 0.93 ECE2 (0.50) SMN1; SMN2HPGDNPC1ECE2POLB
SCHEMBL10666541 0.88 SMN1; SMN2 (0.59) SMN1; SMN2HPGDNPC1ECE2POLB
SCHEMBL5094898 0.87 KMT2A (0.46) SMN1; SMN2HPGDNPC1ECE2POLB
SCHEMBL10665722 0.86 ECE2 (0.57) SMN1; SMN2HPGDNPC1ECE2POLB
SCHEMBL5086751 0.85 MAPT (0.56) SMN1; SMN2ECE2POLBKMT2AMEN1
SCHEMBL5247659 0.85 KMT2A (0.63) SMN1; SMN2HPGDNPC1POLBKMT2A
SCHEMBL5095832 0.84 ALDH1A1 (0.45) SMN1; SMN2HPGDNPC1ECE2POLB
SCHEMBL10666927 0.83 ECE2 (0.54) SMN1; SMN2HPGDNPC1ECE2POLB
SCHEMBL19181001 0.82 POLB (0.60) SMN1; SMN2HPGDNPC1ECE2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US claimed
EP-1781597-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-05-09 EP disclosed
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US disclosed
WO-2006021256-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds KRT18, TYR, ALPG SMN1; SMN2 4803/4885HPGD 773/4885NPC1 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.